{"SLR NAME":"A meta-analysis of corticosteroids for COVID-19 treatment","References":[{"title1":"Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report","References":[{"title2":"A novel coronavirus from patients with pneumonia in China, 2019.","References":[{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019."}]},{"title2":"Estimates of the severity of coronavirus disease 2019: a model-based analysis.","References":[{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."},{"title3":"Estimates%20of%20the%20severity%20of%20coronavirus%20disease%202019:%20a%20model-based%20analysis."}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.","References":[{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.","References":[{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."}]},{"title2":"Clinical features and short-term outcomes of 102 patients with corona virus disease 2019 in Wuhan, China.","References":[]},{"title2":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.","References":[]},{"title2":"Features of 20,133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.","References":[{"title3":"Features%20of%2020,133%20UK%20patients%20in%20hospital%20with%20covid-19%20using%20the%20ISARIC%20WHO%20Clinical%20Characterisation%20Protocol:%20prospective%20observational%20cohort%20study."},{"title3":"Features%20of%2020,133%20UK%20patients%20in%20hospital%20with%20covid-19%20using%20the%20ISARIC%20WHO%20Clinical%20Characterisation%20Protocol:%20prospective%20observational%20cohort%20study."},{"title3":"Features%20of%2020,133%20UK%20patients%20in%20hospital%20with%20covid-19%20using%20the%20ISARIC%20WHO%20Clinical%20Characterisation%20Protocol:%20prospective%20observational%20cohort%20study."},{"title3":"Features%20of%2020,133%20UK%20patients%20in%20hospital%20with%20covid-19%20using%20the%20ISARIC%20WHO%20Clinical%20Characterisation%20Protocol:%20prospective%20observational%20cohort%20study."},{"title3":"Features%20of%2020,133%20UK%20patients%20in%20hospital%20with%20covid-19%20using%20the%20ISARIC%20WHO%20Clinical%20Characterisation%20Protocol:%20prospective%20observational%20cohort%20study."},{"title3":"Features%20of%2020,133%20UK%20patients%20in%20hospital%20with%20covid-19%20using%20the%20ISARIC%20WHO%20Clinical%20Characterisation%20Protocol:%20prospective%20observational%20cohort%20study."},{"title3":"Features%20of%2020,133%20UK%20patients%20in%20hospital%20with%20covid-19%20using%20the%20ISARIC%20WHO%20Clinical%20Characterisation%20Protocol:%20prospective%20observational%20cohort%20study."},{"title3":"Features%20of%2020,133%20UK%20patients%20in%20hospital%20with%20covid-19%20using%20the%20ISARIC%20WHO%20Clinical%20Characterisation%20Protocol:%20prospective%20observational%20cohort%20study."},{"title3":"Features%20of%2020,133%20UK%20patients%20in%20hospital%20with%20covid-19%20using%20the%20ISARIC%20WHO%20Clinical%20Characterisation%20Protocol:%20prospective%20observational%20cohort%20study."},{"title3":"Features%20of%2020,133%20UK%20patients%20in%20hospital%20with%20covid-19%20using%20the%20ISARIC%20WHO%20Clinical%20Characterisation%20Protocol:%20prospective%20observational%20cohort%20study."},{"title3":"Features%20of%2020,133%20UK%20patients%20in%20hospital%20with%20covid-19%20using%20the%20ISARIC%20WHO%20Clinical%20Characterisation%20Protocol:%20prospective%20observational%20cohort%20study."},{"title3":"Features%20of%2020,133%20UK%20patients%20in%20hospital%20with%20covid-19%20using%20the%20ISARIC%20WHO%20Clinical%20Characterisation%20Protocol:%20prospective%20observational%20cohort%20study."},{"title3":"Features%20of%2020,133%20UK%20patients%20in%20hospital%20with%20covid-19%20using%20the%20ISARIC%20WHO%20Clinical%20Characterisation%20Protocol:%20prospective%20observational%20cohort%20study."},{"title3":"Features%20of%2020,133%20UK%20patients%20in%20hospital%20with%20covid-19%20using%20the%20ISARIC%20WHO%20Clinical%20Characterisation%20Protocol:%20prospective%20observational%20cohort%20study."},{"title3":"Features%20of%2020,133%20UK%20patients%20in%20hospital%20with%20covid-19%20using%20the%20ISARIC%20WHO%20Clinical%20Characterisation%20Protocol:%20prospective%20observational%20cohort%20study."},{"title3":"Features%20of%2020,133%20UK%20patients%20in%20hospital%20with%20covid-19%20using%20the%20ISARIC%20WHO%20Clinical%20Characterisation%20Protocol:%20prospective%20observational%20cohort%20study."},{"title3":"Features%20of%2020,133%20UK%20patients%20in%20hospital%20with%20covid-19%20using%20the%20ISARIC%20WHO%20Clinical%20Characterisation%20Protocol:%20prospective%20observational%20cohort%20study."},{"title3":"Features%20of%2020,133%20UK%20patients%20in%20hospital%20with%20covid-19%20using%20the%20ISARIC%20WHO%20Clinical%20Characterisation%20Protocol:%20prospective%20observational%20cohort%20study."},{"title3":"Features%20of%2020,133%20UK%20patients%20in%20hospital%20with%20covid-19%20using%20the%20ISARIC%20WHO%20Clinical%20Characterisation%20Protocol:%20prospective%20observational%20cohort%20study."},{"title3":"Features%20of%2020,133%20UK%20patients%20in%20hospital%20with%20covid-19%20using%20the%20ISARIC%20WHO%20Clinical%20Characterisation%20Protocol:%20prospective%20observational%20cohort%20study."},{"title3":"Features%20of%2020,133%20UK%20patients%20in%20hospital%20with%20covid-19%20using%20the%20ISARIC%20WHO%20Clinical%20Characterisation%20Protocol:%20prospective%20observational%20cohort%20study."},{"title3":"Features%20of%2020,133%20UK%20patients%20in%20hospital%20with%20covid-19%20using%20the%20ISARIC%20WHO%20Clinical%20Characterisation%20Protocol:%20prospective%20observational%20cohort%20study."},{"title3":"Features%20of%2020,133%20UK%20patients%20in%20hospital%20with%20covid-19%20using%20the%20ISARIC%20WHO%20Clinical%20Characterisation%20Protocol:%20prospective%20observational%20cohort%20study."},{"title3":"Features%20of%2020,133%20UK%20patients%20in%20hospital%20with%20covid-19%20using%20the%20ISARIC%20WHO%20Clinical%20Characterisation%20Protocol:%20prospective%20observational%20cohort%20study."}]},{"title2":"Remdesivir for the treatment of Covid-19 : preliminary report.","References":[]},{"title2":"Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.","References":[{"title3":"Pulmonary%20post-mortem%20findings%20in%20a%20series%20of%20COVID-19%20cases%20from%20northern%20Italy:%20a%20two-centre%20descriptive%20study."},{"title3":"Pulmonary%20post-mortem%20findings%20in%20a%20series%20of%20COVID-19%20cases%20from%20northern%20Italy:%20a%20two-centre%20descriptive%20study."},{"title3":"Pulmonary%20post-mortem%20findings%20in%20a%20series%20of%20COVID-19%20cases%20from%20northern%20Italy:%20a%20two-centre%20descriptive%20study."},{"title3":"Pulmonary%20post-mortem%20findings%20in%20a%20series%20of%20COVID-19%20cases%20from%20northern%20Italy:%20a%20two-centre%20descriptive%20study."},{"title3":"Pulmonary%20post-mortem%20findings%20in%20a%20series%20of%20COVID-19%20cases%20from%20northern%20Italy:%20a%20two-centre%20descriptive%20study."},{"title3":"Pulmonary%20post-mortem%20findings%20in%20a%20series%20of%20COVID-19%20cases%20from%20northern%20Italy:%20a%20two-centre%20descriptive%20study."},{"title3":"Pulmonary%20post-mortem%20findings%20in%20a%20series%20of%20COVID-19%20cases%20from%20northern%20Italy:%20a%20two-centre%20descriptive%20study."},{"title3":"Pulmonary%20post-mortem%20findings%20in%20a%20series%20of%20COVID-19%20cases%20from%20northern%20Italy:%20a%20two-centre%20descriptive%20study."},{"title3":"Pulmonary%20post-mortem%20findings%20in%20a%20series%20of%20COVID-19%20cases%20from%20northern%20Italy:%20a%20two-centre%20descriptive%20study."},{"title3":"Pulmonary%20post-mortem%20findings%20in%20a%20series%20of%20COVID-19%20cases%20from%20northern%20Italy:%20a%20two-centre%20descriptive%20study."},{"title3":"Pulmonary%20post-mortem%20findings%20in%20a%20series%20of%20COVID-19%20cases%20from%20northern%20Italy:%20a%20two-centre%20descriptive%20study."},{"title3":"Pulmonary%20post-mortem%20findings%20in%20a%20series%20of%20COVID-19%20cases%20from%20northern%20Italy:%20a%20two-centre%20descriptive%20study."},{"title3":"Pulmonary%20post-mortem%20findings%20in%20a%20series%20of%20COVID-19%20cases%20from%20northern%20Italy:%20a%20two-centre%20descriptive%20study."},{"title3":"Pulmonary%20post-mortem%20findings%20in%20a%20series%20of%20COVID-19%20cases%20from%20northern%20Italy:%20a%20two-centre%20descriptive%20study."},{"title3":"Pulmonary%20post-mortem%20findings%20in%20a%20series%20of%20COVID-19%20cases%20from%20northern%20Italy:%20a%20two-centre%20descriptive%20study."},{"title3":"Pulmonary%20post-mortem%20findings%20in%20a%20series%20of%20COVID-19%20cases%20from%20northern%20Italy:%20a%20two-centre%20descriptive%20study."},{"title3":"Pulmonary%20post-mortem%20findings%20in%20a%20series%20of%20COVID-19%20cases%20from%20northern%20Italy:%20a%20two-centre%20descriptive%20study."},{"title3":"Pulmonary%20post-mortem%20findings%20in%20a%20series%20of%20COVID-19%20cases%20from%20northern%20Italy:%20a%20two-centre%20descriptive%20study."},{"title3":"Pulmonary%20post-mortem%20findings%20in%20a%20series%20of%20COVID-19%20cases%20from%20northern%20Italy:%20a%20two-centre%20descriptive%20study."},{"title3":"Pulmonary%20post-mortem%20findings%20in%20a%20series%20of%20COVID-19%20cases%20from%20northern%20Italy:%20a%20two-centre%20descriptive%20study."}]},{"title2":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.","References":[]},{"title2":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome.","References":[{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome."}]},{"title2":"Influenza : time to target the host?","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.","References":[{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."}]},{"title2":"Cytokine release syndrome in severe COVID-19.","References":[{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."},{"title3":"Cytokine%20release%20syndrome%20in%20severe%20COVID-19."}]},{"title2":"On the use of corticosteroids for 2019-nCoV pneumonia.","References":[{"title3":"On%20the%20use%20of%20corticosteroids%20for%202019-nCoV%20pneumonia."},{"title3":"On%20the%20use%20of%20corticosteroids%20for%202019-nCoV%20pneumonia."},{"title3":"On%20the%20use%20of%20corticosteroids%20for%202019-nCoV%20pneumonia."},{"title3":"On%20the%20use%20of%20corticosteroids%20for%202019-nCoV%20pneumonia."},{"title3":"On%20the%20use%20of%20corticosteroids%20for%202019-nCoV%20pneumonia."},{"title3":"On%20the%20use%20of%20corticosteroids%20for%202019-nCoV%20pneumonia."},{"title3":"On%20the%20use%20of%20corticosteroids%20for%202019-nCoV%20pneumonia."},{"title3":"On%20the%20use%20of%20corticosteroids%20for%202019-nCoV%20pneumonia."}]},{"title2":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.","References":[]},{"title2":"GLUCOCOVID: a controlled trial of methylprednisolone in adults hospitalized with COVID-19 pneumonia.","References":[]},{"title2":"Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review.","References":[]},{"title2":"Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia","References":[]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China.","References":[]},{"title2":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series.","References":[]},{"title2":"Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial.","References":[]},{"title2":"Why do we need some large, simple randomized trials?","References":[]},{"title2":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.","References":[]},{"title2":"The magic of randomization versus the myth of real-world evidence.","References":[]},{"title2":"Modernising epidemic science: enabling patient-centred research during epidemics.","References":[{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."},{"title3":"Modernising%20epidemic%20science:%20enabling%20patient-centred%20research%20during%20epidemics."}]},{"title2":"SARS: systematic review of treatment effects.","References":[{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects."}]},{"title2":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome.","References":[]},{"title2":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis.","References":[]},{"title2":"Corticosteroid therapy for patients hospitalized with community-acquired pneumonia: a systematic review and meta-analysis.","References":[]},{"title2":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients.","References":[]},{"title2":"Viral loads and duration of viral shedding in adult patients hospitalized with influenza.","References":[]},{"title2":"Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome.","References":[{"title3":"Viral%20shedding%20patterns%20of%20coronavirus%20in%20patients%20with%20probable%20severe%20acute%20respiratory%20syndrome."},{"title3":"Viral%20shedding%20patterns%20of%20coronavirus%20in%20patients%20with%20probable%20severe%20acute%20respiratory%20syndrome."},{"title3":"Viral%20shedding%20patterns%20of%20coronavirus%20in%20patients%20with%20probable%20severe%20acute%20respiratory%20syndrome."},{"title3":"Viral%20shedding%20patterns%20of%20coronavirus%20in%20patients%20with%20probable%20severe%20acute%20respiratory%20syndrome."},{"title3":"Viral%20shedding%20patterns%20of%20coronavirus%20in%20patients%20with%20probable%20severe%20acute%20respiratory%20syndrome."}]},{"title2":"Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.","References":[{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study."}]},{"title2":"Viral dynamics in asymptomatic patients with COVID-19.","References":[{"title3":"Viral%20dynamics%20in%20asymptomatic%20patients%20with%20COVID-19."},{"title3":"Viral%20dynamics%20in%20asymptomatic%20patients%20with%20COVID-19."},{"title3":"Viral%20dynamics%20in%20asymptomatic%20patients%20with%20COVID-19."},{"title3":"Viral%20dynamics%20in%20asymptomatic%20patients%20with%20COVID-19."},{"title3":"Viral%20dynamics%20in%20asymptomatic%20patients%20with%20COVID-19."},{"title3":"Viral%20dynamics%20in%20asymptomatic%20patients%20with%20COVID-19."},{"title3":"Viral%20dynamics%20in%20asymptomatic%20patients%20with%20COVID-19."},{"title3":"Viral%20dynamics%20in%20asymptomatic%20patients%20with%20COVID-19."},{"title3":"Viral%20dynamics%20in%20asymptomatic%20patients%20with%20COVID-19."},{"title3":"Viral%20dynamics%20in%20asymptomatic%20patients%20with%20COVID-19."},{"title3":"Viral%20dynamics%20in%20asymptomatic%20patients%20with%20COVID-19."},{"title3":"Viral%20dynamics%20in%20asymptomatic%20patients%20with%20COVID-19."},{"title3":"Viral%20dynamics%20in%20asymptomatic%20patients%20with%20COVID-19."},{"title3":"Viral%20dynamics%20in%20asymptomatic%20patients%20with%20COVID-19."},{"title3":"Viral%20dynamics%20in%20asymptomatic%20patients%20with%20COVID-19."}]},{"title2":"Temporal dynamics in viral shedding and transmissibility of COVID-19.","References":[]},{"title2":"Virological assessment of hospitalized patients with COVID-2019.","References":[]}]}]}